Abstract:BACKGROUND AND PURPOSE: The contrast volume transfer coefficient (K-trans), which reflects blood-brain barrier permeability, is influenced by circulation and measurement conditions. We hypothesized that focal low BBB permeability values can predict the spatial distribution of hemorrhagic transformation and global high BBB permeability values can predict the likelihood of hemorrhagic transformation.MATERIALS AND METHODS: We retrospectively enrolled 106 patients with hemispheric stroke who received intra-arterial thrombolytic treatment. K-trans maps were obtained with first-pass perfusion CT data. The K-trans values at the region level, obtained with the Alberta Stroke Program Early CT Score system, were compared to determine the differences between the hemorrhagic transformation and nonhemorrhagic transformation regions. The K-trans values of the whole ischemic region based on baseline perfusion CT were obtained as a variable to hemorrhagic transformation possibility at the global level.RESULTS: Forty-eight (45.3%) patients had hemorrhagic transformation, and 21 (19.8%) had symptomatic intracranial hemorrhage. At the region level, there were 82 ROIs with hemorrhagic transformation and parenchymal hemorrhage with a mean K-trans, 0.5 0.5/min, which was significantly lower than that in the nonhemorrhagic transformation regions (P < .01). The mean K-trans value of 615 nonhemorrhagic transformation ROIs was 0.7 +/- 0.6/min. At the global level, there was a significant difference (P = .01) between the mean K-trans values of patients with symptomatic intracranial hemorrhage (1.3 +/- 0.9) and those without symptomatic intracranial hemorrhage (0.8 +/- 0.4). Only a high K-trans value at the global level could predict the occurrence of symptomatic intracranial hemorrhage (P < .01; OR = 5.04; 95% CI, 2.01-12.65).CONCLUSIONS: Global high K-trans values can predict the likelihood of hemorrhagic transformation or symptomatic intracranial hemorrhage at the patient level, whereas focal low K-trans values can predict the spatial distributions of hemorrhagic transformation at the region level.

Early Ischemic Blood Brain Barrier Damage: A Potential Indicator for Hemorrhagic Transformation Following Tissue Plasminogen Activator (tpa) Thrombolysis?

Risk factors of hemorrhagic transformation in different locations and its relation to clinical outcomes of patients with acute ischemic stroke following intravenous thrombolysis

Blood-brain barrier disruption and hemorrhagic transformation in acute stroke before endovascular reperfusion therapy

Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells.

D1 Receptor‐mediated Endogenous Tpa Upregulation Contributes to Blood‐brain Barrier Injury after Acute Ischaemic Stroke

tPA Mobilizes Immune Cells that Exacerbate Hemorrhagic Transformation in Stroke

tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?

Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers

Molecular Insights and Therapeutic Targets for Blood–brain Barrier Disruption in Ischemic Stroke: Critical Role of Matrix Metalloproteinases and Tissue-Type Plasminogen Activator

Multi-mode MRI-based Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator(rtpa)reduces Hemorrhagic Transformation in Ischemic Stroke Patients

Optimal Delay Time of CT Perfusion for Predicting Cerebral Parenchymal Hematoma After Intra-Arterial tPA Treatment.

The Role of Connexin43 in Hemorrhagic Transformation after Thrombolysis in Vivo and in Vitro.

Increased Blood-Brain Barrier Permeability in Contralateral Hemisphere Predicts Worse Outcome in Acute Ischemic Stroke after Reperfusion Therapy.

Neurovascular Inflammation and Complications of Thrombolysis Therapy in Stroke

The Relationship Between T2 White-Matter Hyperintensities and Hemorrhagic Transformation and Neurological Outcome after Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Early Blood-Brain Barrier Disruption after Mechanical Thrombectomy in Acute Ischemic Stroke.

Spatiotemporal Evolution of Blood Brain Barrier Damage and Tissue Infarction Within the First 3h after Ischemia Onset

Risk factors and prognosis for hemorrhagic transformation caused by intravenous thrombolysis treatment with recombinant tissue plasminogen activator treatment in acute cerebral infarction

Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model

Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke

Focal Low and Global High Permeability Predict the Possibility, Risk, and Location of Hemorrhagic Transformation Following Intra-Arterial Thrombolysis Therapy in Acute Stroke.